Fineline Cube

Follow:
14435 Articles
Huadong Medicine's First-in-Class ADC HDM2012 Gains FDA Phase I Trial Clearance
CompanyDrug

Huadong Medicine’s First-in-Class ADC HDM2012 Gains FDA Phase I Trial Clearance

China Unveils Measures to Boost Innovative Drug Development With Insurance Data Support
Policy / Regulatory

China Unveils Measures to Boost Innovative Drug Development With Insurance Data Support

HutchMed's Orpathys Approved in China for EGFR-MET Co-Mutation NSCLC
CompanyDeals

HutchMed’s Orpathys Approved in China for EGFR-MET Co-Mutation NSCLC

Recbio Partners with Biological E for HPV VaccineREC603's India and Global Expansion
CompanyDeals

Recbio Partners with Biological E for HPV VaccineREC603’s India and Global Expansion

Astellas Pharma's Vyloy Gains First Prescriptions Across China for Gastric Cancer
CompanyDrug

Astellas Pharma’s Vyloy Gains First Prescriptions Across China for Gastric Cancer

Guangdong Announces First Batch of Approved Innovative Drugs and Medical Devices
Others

Guangdong Announces First Batch of Approved Innovative Drugs and Medical Devices

Santen's Tapcom Administered to First Patient in GBA via Drug Access Policy
CompanyDrug

Santen’s Tapcom Administered to First Patient in GBA via Drug Access Policy

Zhaoke Ophthalmology Partners with Jamjoom Pharma for Cyclosporine Eye Gel Distribution in Middle East
CompanyDeals

Zhaoke Ophthalmology Partners with Jamjoom Pharma for Cyclosporine Eye Gel Distribution in Middle East

Ascletis Faces Patent Challenge from CSPC Subsidiary Conjupro Bio
CompanyDrug

Ascletis Faces Patent Challenge from CSPC Subsidiary Conjupro Bio

Fosun Pharma Secures Licensing Deal for HCB101 SIRPα-Fc Fusion Protein
CompanyDeals

Fosun Pharma Secures Licensing Deal for HCB101 SIRPα-Fc Fusion Protein

Zai Lab's Bemarituzumab Meets Phase III Endpoint in Gastric Cancer Trial
CompanyDrug

Zai Lab’s Bemarituzumab Meets Phase III Endpoint in Gastric Cancer Trial

Hengrui Pharmaceuticals' Aihengping Gains NMPA Approval for Regional Analgesia
CompanyDrug

Hengrui Pharmaceuticals’ Aihengping Gains NMPA Approval for Regional Analgesia